New incident report
Incident Report Number: 2016-5029
Registrant Reference Number: 1830257
Registrant Name (Full Legal Name no abbreviations): McLaughlin Gormley King Company
Address: 8810 Tenth Ave North
City: Minneapolis
Prov / State: MN
Country: USA
Postal Code: 55427-4319
Domestic Animal
Country: UNITED STATES
Prov / State: NEW HAMPSHIRE
Unknown
PMRA Registration No. PMRA Submission No. EPA Registration No. 1021-2684-89459
Product Name: Adams Flea And Tick Dip For Dogs And Cats
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Medical Professional
Other / Autre
specify Exotic
Ferret
1
Male
5
2.30
lbs
Unknown
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
Yes
No
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
8/26/2016 The following report was forwarded for documentation. The report states that owner used the flea dip on a ferret on 5/28/2016 as well as a dewormer. The following morning the ferret had an episode where he seemed to race around for a short time and then collapsed. He was recumbent and not responsive. The veterinarian suspected the ferret was hypoglycemic. They gave Karo syrup at the emergency clinic, and he became somewhat responsive. On 5/29/2016 ferret's clinical status was listed as death. 6/6/2016 No necropsy was performed. 6/10/2016 Toxicologist interacted with ferret owner. Toxicologist reviewed the case with the owner. Toxicologist stated it is not the insecticide or dewormer that caused the ferret to die, and could have been neoplasia or heart disease. Without a necropsy the cause will never be known.
Death
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.